摘要
骨髓增生异常综合征(MDS)是一组起源于造血干(祖)细胞的克隆性异质性疾患,其异质性不仅表现在外周血和骨髓象上,也表现在细胞遗传学、病程、转归和对治疗的反应上.MDS遗传学分型应是一种能反映疾病本质的分型方法 .国内应开展MDS遗传学分型的生物学特征研究,以MDS遗传学分型指导MDS的临床分型治疗,提高其临床疗效.
Myelodysplastic syndromes (MDS) are heterogeneous clonal stem cell disorders characterised not only by peripheral cytopenia and bone marrow hyperplasia but also by karyotype. The course of disease, clinical outcome and response to treatment. Cytogenetic categories is a pattern typing the intrinsical features of MDS. It is suggested here that investigating biological characters and group treatment in MDS based on cytogenetic categories may enhance the therapeutic effect and bring benefit to MDS patients.
出处
《白血病.淋巴瘤》
CAS
2010年第5期262-264,共3页
Journal of Leukemia & Lymphoma